Exposure to Different Amounts of Dietary Gluten in Patients with Non-Celiac Gluten Sensitivity (NCGS): An Exploratory Study.
Study Goal
The researchers aimed to determine whether patients with non-celiac gluten sensitivity (NCGS) could tolerate gluten after reintroducing it into their diet following a gluten-free period.
Results Summary
The study evaluated gastrointestinal symptoms and quality of life in NCGS patients after reintroducing gluten, comparing different gluten intake levels. Results indicated varying tolerance levels among patients, with some experiencing symptom recurrence.
Population
22 NCGS patients with functional gastroenterological symptoms.
Effective Dosage
3.5 g gluten/day (low-gluten diet group).
Duration
3 weeks on gluten-free diet, followed by incremental gluten reintroduction.
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
gluten-free diet (GFD) | neutral | gastrointestinal symptoms and quality of life | NCGS patients | - | changes of both gastrointestinal symptoms and quality of life | #1 |
incremental gluten-containing diets | neutral | gastrointestinal symptoms and quality of life | NCGS patients | - | re-introduction of dietary gluten | #2 |
low-gluten diet (3.5 g gluten/day, week 1) | no change | gluten | NCGS patients | - | tolerating | #3 |
It is unclear whether patients with non-celiac gluten sensitivity (NCGS) can tolerate gluten. We have evaluated the changes of both gastrointestinal symptoms and quality of life for NCGS patients after the re-introduction of dietary gluten. Twenty-two NCGS patients reporting functional gastroenterological symptoms and on gluten-free diet (GFD) for the previous three weeks were exposed to incremental gluten-containing diets. Three groups were compared at baseline (immediately after 3-weeks on GFD) and immediately after the return of symptomatology: (i) a group tolerating a low-gluten diet (3.5 g gluten/day, week 1,